Flonase and Skin hyperpigmentation - a phase IV clinical study of FDA data

Summary:

Skin hyperpigmentation is reported as a side effect among people who take Flonase (fluticasone propionate), especially for people who are female, 30-39 old, also take Tylenol, and have Acne.

The phase IV clinical study analyzes which people have Skin hyperpigmentation when taking Flonase. It is created by eHealthMe based on reports of 73,331 people who have side effects when taking Flonase from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Skin hyperpigmentation?

Skin hyperpigmentation (disorders affect the colour of your skin) is found to be associated with 641 drugs and 812 conditions by eHealthMe. Check the latest studies of Skin hyperpigmentation.

On Aug, 08, 2026

73,331 people reported to have side effects when taking Flonase.
Among them, 20 people (0.03%) have Skin hyperpigmentation.

Could Flonase cause Skin hyperpigmentation?

Among these 20 people:

What is the gender of people who have Skin hyperpigmentation when taking Flonase? *

female: 90 %
male: 10 %

What is the age of people who have Skin hyperpigmentation when taking Flonase? *

What are other drugs people take besides Flonase? *

What are other side effects people have besides Skin hyperpigmentation? *

Rashes (redness): 9 people, 45.00%
Stress And Anxiety: 7 people, 35.00%
Acute Kidney Failure: 7 people, 35.00%
Pain: 7 people, 35.00%
Weakness: 6 people, 30.00%
Emotional Distress: 6 people, 30.00%
Memory Loss: 6 people, 30.00%
Depression: 6 people, 30.00%
Headache (pain in head): 6 people, 30.00%
Nausea And Vomiting: 5 people, 25.00%

What are the existing conditions these people have? *

Acne (skin problems that cause pimples): 5 people, 25.00%
Multiple Myeloma (cancer of the plasma cells): 4 people, 20.00%
Kidney Infection (Pyelonephritis): 3 people, 15.00%
Bone Loss: 3 people, 15.00%
Upper Respiratory Tract Infection: 3 people, 15.00%
Depression: 3 people, 15.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 15.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 15.00%
Nuclear Magnetic Resonance Imaging Abdominal: 2 people, 10.00%
Birth Control: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and have Skin hyperpigmentation?

- Check whether Skin hyperpigmentation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flonase:

Flonase (75,441 reports)

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hyperpigmentation:

Skin hyperpigmentation (641 drugs)

Browse all the conditions that are associated with Skin hyperpigmentation:

Skin hyperpigmentation (812 conditions)

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Flonase) and Flonase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.